sábado, 2 de noviembre de 2024

For the 24 million people globally who suffer from schizophrenia, newly approved Cobenfy offers a breakthrough treatment Daniel Gilbert | Washington Post | November 1, 2024

https://geneticliteracyproject.org/2024/11/01/for-the-24-million-people-globally-who-suffer-from-schizophrenia-newly-approved-cobenfy-offers-a-breakthrough-treatment/?mc_cid=2bbcbe07aa&mc_eid=b73600b7ac

No hay comentarios:

Publicar un comentario